Martin Goldberg

Marty is Vice President of Product Development at Seer. Prior to Seer, Marty was at Talis Biomedical Corporation where he served most recently as Sr. VP, Operations, and prior to that, Sr. VP Research & Development. Before joining Talis, he was Chief Operating Officer at Gen9, a synthetic biology startup. Marty was at Affymetrix from 1993 to 2010 in roles of increasing responsibility, where he established and oversaw the company’s first wafer-scale manufacturing facility, and also as Sr. VP R&D, where he had responsibility for the commercialization of numerous GeneChip® products ranging from new gene expression, genotyping or cytogenetic detection arrays to the launch of the GeneTitan® and GeneAtlas® platforms. Marty holds a Ph.D. in Chemistry from the University of California at San Diego with a focus on physical organometallic chemistry.